U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07077538) titled 'Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients' on June 24.
Brief Summary: The study is a single center, open, prospective, self controlled clinical study. The patients with diabetes who are to be enrolled in peritoneal dialysis are to observe the changes of glycosylated hemoglobin relative to the baseline 90 days after using amino acid (15) peritoneal dialysis solution.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Peritoneal Dialysis
Diabetes
Intervention:
DRUG: Amino acid peritoneal dialysis solution
After breakfast daily, use a bag of amino acid (15) peritoneal dialysis...